Immunoclin Corp Increase (Decrease) in Deferred Revenue
Immunoclin Corp reported Increase (Decrease) in Deferred Revenue of $143.13 thousand for the 9-month period ending 2014-10-31, per its 10-Q filed 2014-12-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2014-12-22
- 2014-10-31: Increase (Decrease) in Deferred Revenue 9 month $143.13K.
| Period end | Increase (Decrease) in Deferred Revenue 9 month |
|---|---|
| 2014-10-31 | $143.13K 10-Q · filed 2014-12-22 |